Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nithyananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
该公司进入各个市场的顺序 — 从最早到最新
Business Development Manager
印度股市收高，制药股受关注
注册以查看完整信号动态
AUROBINDO PHARMA LTD 的国际扩张与竞争对手的对比情况
AUROBINDO PHARMA LTD你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 AUROBINDO PHARMA LTD你 | 0 | 0 | 0% | 0 | 31 |
Business Development Manager
查看职位Ho Chi Minh City, Vietnam · 5个月前
Interesting Job Opportunity: Eugia Pharma - Manager - Production QMS
查看职位Naidupeta, Andhra Pradesh, India · 5个月前
Assistant Manager
查看职位Naidupeta, Andhra Pradesh, India · 6个月前
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
包括SBI、ITC、Airtel、Hero MotoCorp、Britannia和Trent在内的六家Nifty 50公司将于周四公布第三季度业绩。分析师提供了这些公司的收入和利润预估。
IIFL金融、Piramal企业、Dalmia Bharat等是关键观察股。IIFL批准发行NCD，Piramal面临GST需求，Aditya Birla房地产推出成功项目。
包括IndiGo、Aurobindo Pharma和Dabur India在内的几家印度公司预计将因各种公司发展和财务业绩而出现重大市场行动。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 AUROBINDO PHARMA LTD 的业务、市场和增长信号的快速解答。
